South Korea’s Kakao Healthcare Corp. has introduced an artificial intelligence-based bloodsugar management solution targeting the global digital medical market for diabetes andrelated chronic disease treatment.The wholly owned subsidiary of South Korean mobile platform giant Kakao Corp.announced on Thursday its launch of Pasta, a blood sugar management service utilizingcontinuous glucose monitoring (CGM) devices and smartphones.The Pasta app, available in the Google Play Store and the Apple App Store, is currentlycapable of linking with two CGM devices – the G7 of US medical device manufacturerDexcom Inc. and the CareSens Air of South Korean producer i-SENS Inc.Kakao Healthcare plans to connect Pasta with Mallya, the smart cap for pen injectors ofFrench drug delivery device maker Biocorp acquired by Danish drug maker Novo NordiskA/S through a software development kit (SDK) by the second quarter for the first time in theworld.The South Korean digital healthcare platform operator is set to expand Pasta’s services tochronic diseases related to diabetes and make inroads into other countries starting with Japanfrom this year.“We aim to contribute to reducing diabetes treatment costs of more than 3 trillion won ($2.2billion) a year,” said Kakao Healthcare CEO Hwang Hee.TO COLLECT DATA ON BLOOD SUGAR, LIFESTYLESKakao Healthcare secured the necessary approval for Pasta from South Korea’s Ministry ofFood and Drug Safety in November 2023.When a user selects a CGM model in the Pasta app, it shows how to attach the sensor withdetailed explanations of precautions and connection processes. The app automaticallydisplays real-time blood sugar data through Bluetooth once linked.Pasta analyzes information collected from a patient when he or she uses the CGM device toprovide various data such as blood sugar volatility, readings from the glucose managementindicator (GMI) and average blood sugar.The platform helps users easily understand the correlation between their lifestyles and bloodsugar through simple records and blood glucose data. The app allows users to record not onlytheir exercise, insulin and medication, but also meals’ nutrients and calories by uploadingpictures of the foods they eat. Pasta shows changes in blood sugar depending on varioushabits to help users seek healthy lifestyles on their own while generating reports on theefficacy of certain activities to manage blood glucose based on the users' data.The app also features bulletin boards, which allow users to communicate with othersdepending on their type of blood glucose management, and a community function, whichprovides customized content for management.Kakao Healthcare separately introduced Pasta Connect Pro, a platform that allows medicaldoctors to check users’ blood sugar data through the Pasta app for treatment.The company aims to link Pasta Connect Pro with hospitals’ electronic medical records forthe convenience of patients and doctors. (ICE SEOUL)

Fonte notizia: The Korea Economic Daily